Email this to a friend:

U.S. Cuts $231 Million Deal To Provide 15-Minute COVID-19 At-Home Tests

The Food and Drug Administration gave emergency authorization to Ellume's rapid test in December, after it showed 96% accuracy in a U.S. clinical study.